• Calpeptin Workflows for Pulmonary Fibrosis Research

  2026-09-14

  Calpeptin provides a practical way to probe how calcium-dependent protease activity intersects with cell death, fibroblast activation, and inflammatory signaling. This workflow-focused guide connects calpain inhibition with pulmonary fibrosis research while emphasizing controls, readout selection, and troubleshooting.

• Angiotensin 1/2 (1-6) Research Workflow

  2026-09-14

  Build reproducible cardiovascular, renal, and receptor-binding assays around the sequence-defined Asp-Arg-Val-Tyr-Ile-His hexapeptide. This workflow combines practical handling guidance with a cautious translation of recent spike–receptor binding findings into testable assay designs.

• Captopril: ACE Inhibition Research Guide

  2026-09-13

  Captopril is an ACE inhibitor used to study angiotensin signaling, blood-pressure control, and bradykinin-linked biology. Its strongest translational evidence is cardiovascular, while anticancer activity and apoptosis induction in cancer cells remain preclinical research findings.

• Fumagillin Workflows for MetAP-2 and Angiogenesis

  2026-09-12

  Fumagillin connects mechanistic MetAP-2 inhibition with practical angiogenesis and protozoan assay workflows. This guide explains how to prepare the compound, build concentration-response experiments, interpret the Azumiobodo hoyamushi evidence, and troubleshoot solubility or vehicle-related variability.

• Angiotensin 1/2 (1-6): Assay Design Guide

  2026-09-11

  Angiotensin 1/2 (1-6) is a defined Asp-Arg-Val-Tyr-Ile-His hexapeptide for dissecting renin-angiotensin signaling and vascular assays. This guide focuses on experimental design, preanalytical control, and how to interpret emerging spike-receptor binding data without overstating biological conclusions.

• Z-VAD-FMK: A Causal Map of Cell Death

  2026-09-11

  Z-VAD-FMK is more than an apoptosis blocker: it is a perturbation tool for distinguishing caspase-dependent apoptosis from RIPK1-linked necroptosis. This guide combines mechanistic chemistry, assay design, and insights from a CRISPR-based RIPK1 study to improve interpretation in apoptotic pathway research.

• GSH and GSSG Assay Kit for Tumor Redox Studies

  2026-09-10

  Use paired GSH and GSSG measurements to connect hypoxic tumor biology with immune-cell metabolic adaptation. This workflow emphasizes sample preservation, selective GSSG analysis, matrix control, and practical interpretation rather than treating one redox value as a complete mechanistic answer.

• Metal-Free Carbon Nanozymes for ALP Detection

  2026-09-10

  Hsieh and colleagues developed a metal-free carbon-dot nanozyme assay that converts alkaline phosphatase hydrolysis of pyrophosphate into a colorimetric turn-on signal. Kinetic analysis showed that pyrophosphate inhibits the carbon dots at a site distinct from the catalytic site, supporting sensitive ALP measurement while reducing metal-ion-related interference.

• Demethyleneberberine Workflows for Inflammation & NSCLC

  2026-09-09

  Demethyleneberberine (DMB) supports mechanism-driven inflammation, mitochondrial, and cancer workflows rather than single-endpoint screening. This guide connects practical cell and animal model design with solvent handling, pathway-resolved assays, and troubleshooting for UC, autoimmune hepatitis, and NSCLC research.

• Honokiol: From Mechanism to Measurable Response

  2026-09-09

  A translational framework for using Honokiol to connect NF-κB, redox biology, proliferation, and cell death without confusing pathway modulation with therapeutic response.

• Magnetic Stimulation Targets GABRE in Schizophrenia Mice

  2026-09-08

  A Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a responsive molecular target of selective magnetic stimulation. Using pharmacological, genetic, behavioral, and synaptic approaches, the authors connect GABRE regulation with the reversal of schizophrenia-like phenotypes and implicate p62/SQSTM1–GABARAP trafficking in the response.

• Sphingosine-1-phosphate: From Ligand to Translation

  2026-09-08

  Sphingosine-1-phosphate is a context-dependent signaling tool whose effects range from vascular maturation and survival signaling to receptor-specific neuronal apoptosis. This thought-leadership article connects S1P biology with experimental design, translational positioning, and reproducible workflow strategy.

• Demethyleneberberine in Huntington’s Disease Research

  2026-09-07

  The reference paper proposes Demethyleneberberine (DMB) as a hypothesis-generating, multi-pathway candidate for Huntington’s disease by connecting oxidative stress, mitochondrial dysfunction, neuroinflammation, and neuronal apoptosis. Its main value is mechanistic integration rather than direct therapeutic validation, providing a framework for designing focused preclinical studies.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-09-07

  This 2015 study introduced indazole- and indole-based glucagon receptor antagonists derived from the MK-0893 framework and used focused SAR to optimize key scaffold positions. Several compounds combined strong in vitro activity with favorable rat pharmacokinetics, while GRA 16d produced oral glucose-lowering effects in humanized glucagon receptor mouse models.

• Aminopeptidase Selectivity and ACE Inhibitor Action

  2026-09-05

  The reference study re-evaluated how bestatin and related metallopeptidase inhibitors act across aminopeptidases A, N, and W, revealing that bestatin is relatively selective for AP-W rather than AP-N or AP-A. Its direct comparison of inhibitor classes provides an important caution for interpreting ACE inhibitor experiments: inhibition of angiotensin converting enzyme does not automatically predict inhibition of related cell-surface aminopeptidases.

7749 records 1/517 page Next 12345 下5页 Last page